Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson

The case, which is premised on a unproven legal theory, could impact the course of future opioid litigation."Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson" via FOX BIZ https://fxn.ws/2WUGlae